“…Although obesity can be characterised as an energy storage disorder, it is also associated with low-intensity inflammation, independent of the association between insulin resistance and sub-acute inflammation (Inadera, 2008;Singer and Lumeng, 2017;Mãrginean et al 2020). Many of the illnesses comorbid with obesity (e.g., osteoarthritis, skin disorders, asthma, even cognitive impairment) have an inflammatory component (Vendrell and Chacon, 2013;Krasteva et al, 2018;Stefanadi et al, 2018;Wang and He, 2018;Buie et al, 2019;Suhett et al, 2021), including type 2 diabetes mellitus (T2DM), dyslipidemia, atherosclerosis, and other cardiovascular diseases (CVD) (Herder et al, 2007;Yeste et al, 2007;Carolan et al, 2014;Lund et al, 2020). The discovery of adipocytokines synthesised mainly by adipocytes further suggests an attractive mechanism for molecular signalling between obese adipose tissue and other organ systems.…”